Literature DB >> 33208068

An Overview of Aptamer: The Prominent Applications and Different Computational Tools for its Design.

Mehrdad Ameri1, Sedigheh Eskandari2, Navid Nezafat2.   

Abstract

BACKGROUND: Aptamers are short single-stranded oligonucleotides; due to their 3D structure, they can specifically bind to various targets. They can target several molecules ranging from metal ions, organic components to proteins, and large cells.
METHODS: According to the high affinity of aptamers, they can be used for diagnosis, therapeutic, vaccine development, and gene silencing applications. The conventional method for aptamer selection is known as the Systematic Evolution of Ligands by Exponential (SELEX). However, despite the efficiency of SELEX as a screening procedure, it is beneficial to develop more rational procedures for aptamer selection. RESULTS & DISCUSSION: Herein, in silico approaches can play an effective role given their potential in representing an efficient, cost-effective, parallelizable, and rapid strategy. In recent years, several attempts have been applied to develop algorithms and software for the rational selection of aptamers. However, there is still a need for more efforts to achieve the most efficient techniques in this area.
CONCLUSION: In this review, we aim to overview different computational approaches that are used for aptamer selection. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Aptamer; SELEX; applications; computational tools; design; diagnostic; therapeutic.

Year:  2021        PMID: 33208068     DOI: 10.2174/1389201021666201117112716

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  1 in total

1.  Investigating Efficacy of Three DNA-Aptamers in Targeted Plasmid Delivery to Human Prostate Cancer Cell Lines.

Authors:  Saeedeh Askarian; Niloofar Khandan Nasab; Seyed Hamid Aghaee-Bakhtiari; Mohammad Hassan Jafari Najaf Abadi; Reza Kazemi Oskuee
Journal:  Mol Biotechnol       Date:  2022-07-14       Impact factor: 2.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.